Please use this identifier to cite or link to this item:
https://doi.org/10.18632/oncotarget.9333
Title: | The emerging roles of exosomes in leukemogeneis | Authors: | Zhou, J Wang, S Sun, K Chng, W.-J |
Keywords: | biological marker galectin 3 microRNA 126 somatomedin C receptor transforming growth factor beta receptor 1 antineoplastic agent protein RNA acute myeloblastic leukemia apoptosis biogenesis bone marrow biopsy bone marrow stroma cell cancer chemotherapy cancer diagnosis cancer immunotherapy cancer prognosis cancer resistance cell proliferation cell survival chronic lymphatic leukemia chronic myeloid leukemia dendritic cell drug delivery system exosome flow cytometry graft versus host reaction human immune response in vivo study leukemia leukemia cell leukemogenesis mesenchymal stem cell nonhuman Review tumor escape tumor microenvironment tumor vascularization animal cell communication cell motion drug resistance endosome exosome gene expression regulation immunotherapy leukemia metabolism mouse neovascularization (pathology) prognosis treatment outcome Animals Antineoplastic Agents Cell Communication Cell Movement Cell Proliferation Cell Survival Drug Resistance, Neoplasm Endosomes Exosomes Gene Expression Regulation, Leukemic Humans Immunotherapy Leukemia Mice Neovascularization, Pathologic Prognosis Proteins RNA Treatment Outcome |
Issue Date: | 2016 | Citation: | Zhou, J, Wang, S, Sun, K, Chng, W.-J (2016). The emerging roles of exosomes in leukemogeneis. Oncotarget 7 (31) : 50698-50707. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.9333 | Rights: | Attribution 4.0 International | Abstract: | Communication between leukemia cells and their environment is essential for the development and progression of leukemia. Exosomes are microvesicles secreted by many types of cells that contain protein and RNA and mediate intercellular communication. The involvement of exosomes has been demonstrated in the crosstalk between leukemic cells, stromal cells and endothelial cells, consequently promoting the survival of leukemic cells, protection of leukemic cells from the cytotoxic effects of chemotherapeutic drugs, angiogenesis and cell migration. At the same time, exosomes can be used for the detection and monitoring of leukemia, with some advantage over current methods of detection and surveillance. As they are involved in immune response towards leukemic cells, exosomes can also potentially be exploited to augment immunotherapy in leukemia. In this review, we first describe the general characteristics of exosomes and biogenesis of exosomes. We then highlight the emerging role of exosomes in different types of leukemia. Finally, the clinical value of exosomes as biomarkers, in vivo drug carriers and novel exosome-based immunotherapy are discussed. | Source Title: | Oncotarget | URI: | https://scholarbank.nus.edu.sg/handle/10635/179969 | ISSN: | 19492553 | DOI: | 10.18632/oncotarget.9333 | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_18632_oncotarget_9333.pdf | 963.24 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License